Skip to main navigation

About Us
Technology
Pipeline
Patients
Clinical Trials
Collaborations
Investors + Media
Careers

About Us
Technology
Pipeline
Patients
Clinical Trials
Collaborations
Investors + Media
Careers

Events

Investors + Media
Stock Information
News Releases
Events + Presentations
Financials + SEC Filings
Corporate Governance

Events

Presentations

Sangamo Corporate Presentation February 2021

February 24, 2021

ASH 2020: Update for the Alta Study, a Phase 1/2 Gene Therapy Trial of Giroctocogene Fitelparvovec (SB-525) in Adults With Severe Hemophilia A

December 7, 2020

Upcoming Events

More events are coming soon.

Past Events

Sangamo R&D Day

Dec 17, 2019 at 8:00 AM EST

Sangamo 3rd Quarter 2019 Teleconference Call

Nov 6, 2019 at 2:00 PM PST

Sangamo 2nd Quarter 2019 Teleconference Call

Aug 7, 2019 at 2:00 PM PDT

Sangamo 1st Quarter 2019 Teleconference Call

May 8, 2019 at 5:00 PM EDT

Sangamo 4th Quarter and Full Year 2018 Teleconference Call

Feb 28, 2019 at 2:00 PM PST

Pagination

Previous page
Page 1
Page 2
Current page 3

© Sangamo Therapeutics

Disclaimer
Privacy Policy